Name: Amaryl (Glimepiride) 4mg Tabs x30
Price: 19200 NGN
Availability: InStock

Amaryl (Glimepiride) 4mg Tabs x30

Please be aware that prices may vary due to fluctuations in the market, and adjustments may be made without advance notice.

Amaryl 4mg Glimepiride Is Used To Control High Blood Sugar In People With Type 2 Diabetes. It May Also Be Used With Other Diabetes Medications.

₦19,200.00

Buy Now

Availability: In Stock

Brands:Sanofi

Amaryl 4mg tablets contain glimepiride, an oral diabetes drug that lowers blood sugar by increasing insulin secretion from the pancreas.

Uses

Amaryl 4mg is used along with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It can be used as monotherapy or in combination treatment plans.

Benefits

Amaryl can effectively lower HbA1c levels in diabetics by enhancing insulin output through pancreatic beta cell pathways. This provides sustained glycemic control.

Mechanism of Action

Glimepiride acts on ATP-sensitive potassium channels in pancreatic cells, causing membrane depolarization and calcium influx, which stimulates insulin release.

Dosage
The starting dose for Amaryl 4mg is 1 tablet daily right before breakfast or the first main meal. This can be adjusted up to 4mg twice daily based on blood glucose response.

Warnings

Amaryl may cause dangerously low blood sugar. Inform your doctor about liver/kidney disease, history of jaundice, heart failure, and other medications taken.

Important Information
Monitor blood sugar closely when on glimepiride. Educate yourself on managing hypoglycemia. Seek immediate medical care if symptoms persist.

AMARYL should be administered with breakfast or the first main meal of the day. The recommended starting dose of AMARYL is 1 mg or 2 mg once daily. Patients at increased risk for hypoglycemia (e.g., the elderly or patients with renal impairment) should be started on 1 mg once daily WARNINGS AND PRECAUTIONS and Use in Specific Populations]. After reaching a daily dose of 2 mg, further dose increases can be made in increments of 1 mg or 2 mg based upon the patient's glycemic response. Uptitration should not occur more frequently than every 1-2 weeks. A conservative titration scheme is recommended for patients at increased risk for hypoglycemia The maximum recommended dose is 8 mg once daily. Patients being transferred to AMARYL from longer half-life sulfonylureas (e.g., chlorpropamide) may have overlapping drug effect for 1-2 weeks and should be appropriately monitored for hypoglycemia.